Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Biochemical Pharmacology|July 1, 1988
Protective action of prostaglandin E1 (PGE1) against constrictor mediators in isolated rat heart and lungZ Terashita, G L Stahl, A M Lefer
European Journal of Pharmacology|February 26, 1985
Delay of the initiation of hypertension in spontaneously hypertensive rats by CV-4151, a specific thromboxane A2 synthetase inhibitorY Shibouta, Z Terashita, Y Inada, et al.
European Journal of Pharmacology|March 15, 1988
The thromboxane A2/prostaglandin endoperoxide receptor antagonist activity of CV-4151, a thromboxane A2 synthetase inhibitorY Imura, Z Terashita, Y Shibouta, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1988
Role of platelet activating factor in propagation of cardiac damage during myocardial ischemiaG L Stahl, Z Terashita, A M Lefer
European Journal of Pharmacology|February 26, 1985
Is platelet activating factor (PAF) a mediator of endotoxin shock?Z Terashita, Y Imura, K Nishikawa, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|April 1, 1986
[Antagonism of collagen-induced ECG changes in rats by a thromboxane synthetase inhibitor, CV-4151]H Matsumura, Z Terashita, K Nishikawa, et al.
Pageof 6